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Summary 
Objectives
This study aimed to assess the psychometric properties of the 
Italian versions of the Devaluation of Consumers Scale (DCS) 
and the Devaluation of Consumer Families Scale (DCFS), two 
short-scales examining public stigma towards people with men-
tal disorders and their relatives.
Methods
The scales were administered to 117 individuals with a clini-
cal diagnosis of affective or non-affective psychoses (ICD 10 
criteria F20-29, F30-33). Translation procedures were carried 
out according to accepted standards. Internal reliability was as-
sessed using Cronbach’s alpha coefficient. Convergent validity 
was evaluated in terms of correlation with the Global Function-
ing Scale (GAF) and with the Questionnaire on Users’ Opinions 
(QUO). Known-group validity was assessed comparing patients 
at first-episode of psychosis and patients with a history of psy-
chosis of at least 3 years (long-term psychosis).
Results
The overall Cronbach’s alpha value was 0.85 for DCS and 0.81 
for DCFS; subscales’ alpha values ranged from 0.80 to 0.55 for 
DCS, and from 0.68 to 0.55 for DCFS. Negative correlations 
were found between the Italian DCS and the DCFS total score 
and the QUO affective problems (DCS -0.33; DCFS -0.235) and 
social distance subscales (DCS -0.290; DCFS -0.356). Moreo-
ver, the GAF positively correlated with some of the DCS and 
DCFS subscales. Patients with long-term psychosis had higher 
scores in most DCS and DCFS subscales. 
Conclusion
The Italian translation of DCF and DCFS showed good internal 
consistency, known-group validity, and convergent validity. These 
psychometric properties support their application in routine clini-
cal practice in Italy as well as their use in international studies.
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Introduction
Stigma is a factor associated with negative outcomes in se-
vere mental disorders, especially in schizophrenia 1. Stigma 
negatively affects the quality of life of people with mental 
disorders and their caregivers, as well as the short and long-
term clinical course of psychotic disorders. Examples of the 
negative impact of stigma are delays in care seeking and 
treatment 2, poor therapeutic adherence 3, low social inte-
gration 4, and difficulties in finding or keeping a job 5. These 
negative effects, taken together, result in an increased risk 
for clinical relapse and poor functional recovery.
Stigma may be expressed through three different levels: 
stereotyping (cognitions, beliefs), prejudice (emotions, 
feelings), and discrimination (behaviors). Furthermore, 
stigma is classified in three main types: public stigma, 
self-stigma, and experienced stigma. Public stigma refers 
to what the society or the majority of lay people believe 
about the person with mental health problems; self-stig-
ma expresses the degree of internalization of the stigma 
by the victim; experienced stigma corresponds to objec-
tive discriminations 6. According to the “modified labe-
ling theory” 7, receiving a diagnostic label of schizophre-
nia increases the perception of public negative attitudes 
towards individuals affected with mental disorders (pub-
lic stigma). In people with mental disorders, this “stereo-
type awareness” may lead to internalize such negative at-
titudes and to anticipate possible acts of discrimination 8. 
In other words, stereotype awareness may significantly 
affect users’ self-esteem and self-efficacy, further influ-
encing quality of life and treatment-seeking behaviors. 
Indeed, it was demonstrated that insight, and therefore 
252
L. Sideli et al.
cal diagnosis of schizophrenia (ICD 10 criteria F20), oth-
er non-affective psychoses (ICD 10 F21-29), or affective 
psychoses (F30-33)  26, attending mental health services 
of Palermo (Southern Italy) in the period 2010-2015. In-
clusion criteria were: 1. age between 18 and 65 years; 
2. being resident in Palermo; 3. diagnosis of psychotic 
disorders according to ICD-10 F20-29 or F30-33 crite-
ria. Exclusion criteria were: 1. psychosis due to organic 
causes; 2. presence of severe learning disability. 
Ethical approval was obtained for the EUGEI study by the 
ethical committee of the University Hospital “P. Giac-
cone” of Palermo. Potential participants were informed 
about the study aims and procedures, data anonymi-
zation (carried out by assigning to each participants a 
unique number key), and the possibility to withdraw from 
the study in any moment. Participants that agreed to par-
ticipate in the study signed an informed consent and then 
completed the Devaluation of Consumers scale (DCS), 
the Devaluation of Consumer Families scale (DCFS), 
and the Questionnaire on Users’ Opinions (QUO) about 
schizophrenia. Main socio-demographic characteristics 
were also collected by an ad hoc schedule. Symptom and 
disability severity were registered using the Global As-
sessment of Functioning (GAF) on the basis of clinical 
records and information provided by care coordinators. 
Measures 
The Devaluation of Consumers Scale (DCS) 
The Devaluation of Consumers Scale (DCS) is an eight-
item scale assessing stereotype awareness by patients 
with severe mental disorders 24-27. Factorial analysis 
led to the identification of the following three-factor 
solution (total explained percentage: 68.6%): factor 1 
“status reduction”, describes the altered patients’ sta-
tus in society (five items, 28.7% of variance); factor 2 
“role restriction”, concerns a pessimistic view related 
to the possibility of finding a job or getting married 
(two items, 23.5%); and factor 3 “friendship refusal”, 
accounts for difficulties in establishing friendships (one 
item, 16.4%). Internal consistence of the DCS was es-
timated as 0.82 25.
The Devaluation of Consumers Families Scale (DCFS) 
The Devaluation of Consumers Families Scale (DCFS) 
complements the DCS by assessing the perceived de-
valuation or discrimination towards family members of 
patients with severe mental disorders 24-26. The seven 
items of the DCFS were grouped in three factors, ex-
plaining 71% of the variance. The factors were: fac-
tor 1 “community rejection”, describes the tendency 
to avoid friendships and other forms of social contact 
stigma, are associated with poor therapeutic alliance in 
patients with psychotic spectrum disorders 9. 
Compared to stigma towards people with common and 
socially accepted mental disorders, such as depres-
sion  10  11, public attitudes are particularly negative to-
wards People With Schizophrenia (PWS). A large number 
of studies confirmed that PWS are often viewed as dan-
gerous, unpredictable, and socially impaired. These at-
titudes have been found associated with desire for social 
distance and prognostic pessimism 12-14.
Stigma not only invests people diagnosed with mental 
disorders, but also those around them, primarily their 
caregivers. The so-called “affiliate stigma” or “courtesy 
stigma” 6 15 refers to the process of being stigmatized be-
cause of an association with a stigmatized person. Affiliate 
stigma is associated with increased family burden, as well 
as with stereotype awareness and increased symptoms in 
patients 16 17, suggesting pervasive effects of the stigmatiza-
tion process both on PWS and caregivers’ quality of life. 
Given the relevance of stigma in many domains of the life 
of people with severe mental disorders, it is worthwhile 
measuring stigma – by means of valid and reliable assess-
ment tools – as a first step to promote sensitization and 
educational programs for the public. Some international 
assessment scales on stigma have been recently validat-
ed in Italian, such as the Attribution Questionnaire-27/
AQ-27  18, whereas other instruments, as the Question-
naire on Users’ Opinions/QUO 19 and the Questionnaire 
on Families’ Opinions/QFO  20 have been originally de-
veloped in Italy and subsequently used in different popu-
lations 21-23.
Within the EUGEI project, the most recent epidemiologi-
cal European survey on psychotic disorders 24, stereotype 
awareness towards PWS and their family members were 
assessed using the Devaluation of Consumers Scale (DCS) 
and the Devaluation of Consumer Families Scale (DCFS)25. 
These short-scales stand out for their convenience of ad-
ministration – since they require few minutes to be com-
pleted – the possibility of evaluating public stigma towards 
family members – not covered by other scales – and the 
ability to evaluate various features of public stigma to-
wards mental disorders, such as social status reduction, 
friendship refusal, or community rejection. In this study, 
we report data on the assessment of the psychometric 
properties of the Italian versions of the DCS and the DCFS, 
both administered to a sample of 117 PWS.
Method
Participants and procedure
The scales were administered to individuals with a clini-
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and lower scores indicate greater disability/more severe 
symptoms 29.
Data Analysis
Internal reliability was assessed using Cronbach’s alpha 
coefficient on total scales and related subscales. Con-
vergent validity was evaluated in terms of correlation 
with the GAF and, only for the subgroup of patients 
with long-term psychosis (n = 72), with the QUO; cor-
relations were calculated using Pearson’s r coefficient. 
Known-group validity was assessed by comparing pa-
tients with first-episode of psychosis (FEP) with patients 
affected by long-term psychosis (LTP). Differences be-
tween groups were tested by performing Student’s t test. 
Statistical significance was set at p  <  0.05. Analyses 
were performed using SPSS version 21.
Results
Sample
A total of 117 people with psychosis were assessed. Par-
ticipants had a mean age of 36.32 (sd 12.33) and were 
mostly males (75, 64.1%), with high level of education 
(high school degree 53 (45.3%), middle school degree 45 
(38.5%), primary school degree 19 (16.2%), and single 
(99, 84.6%). 
Seventy-two out of 117 participants had a clinical his-
tory of at least 3 years of psychosis (mean illness dura-
tion 16.64 years, sd 9.93), while 45 participants were 
at their first-episode of psychosis (i.e. presenting for the 
first time to psychiatric services for psychotic symptoms). 
In both groups, most participants were males (patients 
with FEP 25 [55.6%] vs patients with long-term psycho-
sis 50 [69.4%], χ2 = 2.321, p= 0.128), and with high 
level of education (middle school degree 20 [44.4%] 
vs 25 [34.7%] or high school degree 20 [44.4%] vs 33 
[45.8%], χ2 = 1.877, p = 0.391). The two groups were dif-
ferent in their mean age (mean 29.98 [sd 11.38] vs 40.28 
[11.26], t = -4.795, p < 0.001) and marital status (single 
32 [71.1%] vs 67 [93.1%], χ2 = 10.244, p = 0.001).
Internal reliability 
As reported in Table I, Italian DCS had moderate-high in-
ternal reliability both for the total scale (alpha 0.85) and 
the subscales (status reduction alpha 0.80; role restriction 
alpha 0.57). Similar level of internal reliability was found 
for the Italian DCFS (Table I).
Validity 
Analysis of convergent validity showed that the GAF 
functioning subscale positively correlated with the DCS 
with caregivers of patients with psychiatric disorders 
(four items, 32.9% of variance); factor 2 “causal attri-
bution”, is related to the tendency to treat some people 
in a different way because of the disease of their family 
member, and to blame parents for the mental illness of 
their children (two items, 20.9%); and factor 3 “uncar-
ing parents” expresses the view that children affected 
by mental disorders had received inadequate paren-
tal care (one item, 17.2%). The internal consistence of 
DCFS was estimated 0.77. 
The DCS and the DCFS were forward-translated by an 
Italian psychiatrist and an Italian clinical psychologist, 
who agreed on the Italian translations of the two scales. 
Subsequently, the two translations were reviewed and 
approved by a committee of the EU-GEI research pro-
ject coordination, including an Italian mother tongue 
researcher with expertise in psychosis. This was con-
sistent with established methods for translating health 
status instruments 28.
The Questionnaire on Users’ Opinions 
The Questionnaire on Users’ Opinions (QUO) assesses 
users’ view of their own mental disorder. QUO includes 
24 items on the psychosocial impact of severe mental 
disorders, grouped in the following six subscales: “af-
fective problems” (7 items, Cronbach’s alpha 0.73) re-
ferring to patients’ difficulties in establishing relation-
ships, friendships, and set up their own family; “social 
distance” (5 items, alpha 0.74), concerning perceived 
distance, lack of understanding, and fear of “the oth-
ers” towards PWS; “usefulness of drug and psychoso-
cial treatments” (3 items, alpha 0.56), accounting for 
benefits and side effects of psychiatric interventions; 
“right to be informed” (3 items, alpha 0.58) referring to 
users’ right to be informed about own mental problem 
and treatments; “recognizability” (2 items, alpha 0.56) 
examining the belief that PWS are easily identifiable 
because of their symptoms and drugs’ side effects; and 
“social equality” (4 items, alpha 0.55), exploring re-
spondent’s views of discriminations in social and work 
opportunities. Factor analysis identified two factors, the 
former accounting for social and affective impact of se-
vere mental disorders (33.3%) and the latter being re-
lated to clinical outcome and usefulness of treatments 
for schizophrenia (19.5%) 19.
Global Assessment of Functioning 
The DSM-IV Axis V Global Assessment of Functioning 
(GAF) scale is an established tool for the assessment 
of symptom severity and psychosocial functioning in 
clinical and research settings. GAF scales are rated on 
1-100 level, where higher scores correspond to bet-
ter functioning/absent or minor psychiatric symptoms, 
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role restriction subscale, while the GAF symptom sub-
scale positively correlated with the DCFS community re-
fusal subscale. 
Negative correlations were found between the DCS and 
the DCFS total score and the QUO affective problems 
and social distance subscales. Moreover, the DCS status 
reduction and the DCS role restriction subscales nega-
tively correlated with the QUO affective difficulties and 
social distance subscales, while the DCS friendship refus-
al correlated with the QUO usefulness of treatments and 
recognizability subscales. Finally, the DCFS community 
refusal and causal attribution subscales negatively cor-
related with the QUO social distance subscale, whereas 
the DFCS neglecting parents correlated with the QUO af-
fective problems and social distance subscales (Table II). 
Comparisons between the two groups (patients with FEP 
vs patients with LTP) revealed that participants with long-
term psychosis had higher scores than participants at ear-
ly stage of psychosis in all DCS and DCFS subscales, ex-
cept for DCS status reduction and friendship refusal and 
the DCFS causal attribution subscales (Table III).
Discussion 
The results of this study confirm that the Italian version of 
the DCS and DCFS are valid and reliable assessment tools 
to explore public stigma towards PWS and their relatives. 
The Italian DCS had an acceptable to good internal reli-
ability for total scale (Cronbach’s alpha 0.85), and sub-
scales (status reduction: alpha 0.80; role restriction: al-
pha 0.57). Similarly, adequate level of internal reliability 
was found for the Italian DCFS, whose Cronbach’s alphas 
were respectively 0.81 for total scale and 0.68 and 0.56 
for subscales. These values are consistent with those re-
ported in the original version 25, where internal consist-
ency of the DCS and the DCFS were, respectively, 0.82 
and 0.71.
The validity of the Italian DCS and DCFS was investi-
TABLE I. 
Reliability of the Italian Devaluation Consumers’ Scale and 
the Italian Devaluation Consumers’ Family Scale
Items  Cronbach’s alpha 
DCS
   Total Score
   Status reduction
   Role restriction
DCFS 
   Total Score
   Community refusal
   Causal attribution
8
5
2
7
4
2
0.851
0.806
0.558
0.808
0.685
0.558
DCS: Devaluation Consumers’ Scale; DCFS: Devaluation Consumers’ 
Families Scale.
TABLE II. 
Convergent validity of Italian Devaluation Consumers’ Scale and the Italian Devaluation Consumers’ Families Scale.
QUO
n = 72
GAF
N = 117
Affective 
problems
Social 
distance
Usefulness 
of 
treatments
Recognizability Social 
equality
Right 
to be 
informed
Symptoms Functioning 
DCS
Overall score -0.331** -0.290* 0.042 -0.127 -0.053 0.156 0.112 0.135
Status reduction -0.315** -0.235* 0.004 -0.087 -0.057 0.157 0.067 0.095
Role restriction -0.300** -0.305** 0.001 -0.049 -0.058 0.119 0.152 0.192*
Friendship refusal -0.177 -0.230 0.247* -0.298* 0.014 0.089 0.126 0.081
DCFS
Overall score -0.235* -0.356** -0.004 -0.116 -0.087 0.014 0.157 -0.024
Community 
refusal
-0.185 -0.241* 0.023 0.129 -0.031 -0.002 0.205* 0.017
Causal 
attribution
-0.118 -0.318** -0.077 -0.032 -0.169 0.085 0.016 -0.064
Neglecting_parents -0.370** -0.406** -0.039 -0.107 -0.024 -0.079 0.138 -0.042
Pearson r correlations. ** Correlations statistically significant at p < 0.01 ; * Correlations statistically significant at p <. 0.05. 
DCS: Devaluation Consumers’ Scale; DCFS: Devaluation Consumers’ Families Scale; QUO: Questionnaire on Users’ Opinions; GAF: Global 
Functioning Scale.
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gated as known-group validity and as convergent valid-
ity. The higher mean scores of DCS and DCFS found in 
patients with long-term disease compared to those at 
their first-episode of psychosis (see Table 3) could be 
related to the greater experience of public stigma in the 
former. This is partially in line with a previous study re-
porting association between the DCS score and age 16. It 
is likely that the higher mean score found among long-
term psychosis participants is attributable to a deeper 
internalization of negative stereotype, as well as to par-
ticipants’ higher insight about their own condition, and 
to a greater likelihood of having experienced discrimi-
nation and marginalization 30 31. Nevertheless, the lack 
of significant differences in the DCS status reduction 
and friendship refusal and the DCFS causal attribution 
suggests that these dimensions of public stigma might be 
perceived by PWS since the onset of the disease and do 
not vary substantially over time.
Both DCS and DCFS showed significant correlations with 
the QUO. In particular, the DCS status reduction and the 
DCS role restriction subscales positively correlated with 
affective difficulties and social distance as measured by 
QUO, while the DCS friendship refusal subscale nega-
tively correlated with the QUO social recognizability 
subscale. This is consistent with previous studies on clini-
cal samples of people with severe mental disorders show-
ing that public stigma was strongly related to alienation, 
social withdrawal, and stereotypes endorsement  32 33. 
Moreover, we found that the DCS friendship refusal sub-
scale positively correlated with the QUO usefulness of 
treatments subscale, suggesting that perceived public at-
titude towards mental disorders is related with treatment-
seeking behaviors. This association corroborates findings 
reported by Jennings et al. 34 on a large sample of college 
students. A further result concerns the negative correla-
tions of all DCFS subscales with the QUO social distance 
subscale, pointing out at the effects of courtesy stigma on 
social relationships.
DCS and DCFS showed few correlations with the GAF 
subscales. Specifically, the DCS role restriction negatively 
correlated with the GAF functioning scale. This result is in 
line with previous studies showing a relationship between 
public stigma and functional outcome 35-37. It is likely that 
psychosocial functioning and stereotype awareness are 
part of a vicious circle, in which worst functioning leads 
to greater discrimination in employment and social con-
texts, while perceived devaluation prevents PWS from 
looking for a job and intimate relationship, even in ab-
sence of experience of discrimination 24 38. This study also 
found a positive relationship between symptoms severity 
(GAF symptoms scale) and perceived marginalization of 
the families (DCFS community refusal), which replicates 
the findings of previous research on the link between 
courtesy stigma and psychopathology 15 16. These findings 
suggest that the course of severe mental disorders is re-
lated not only to perceived patient’s devaluation but also 
to family devaluation, a condition further contributing to 
self-defeat and isolation of people with psychosis 39 40. 
According to a cognitive model of psychosis, discrimina-
tion and stigma, along with other psychosocial stressors 
(i.e. childhood adversities, see  41 42), might increase the 
risk for psychotic symptoms by promoting negative rep-
resentations of the self and the others, favoring reason-
ing biases, and increasing the sensitivity of the biologi-
TABLE III.
Known group validity of Italian Devaluation Consumers’ Scale and the Italian Devaluation Consumers’ Families Scale.
Patients at their FEP
n = 45
Patients with LTP
n = 72
Students’ t p value
DCS Mean (SD) Mean (SD)
Overall score 2.35 (0.62) 2.65 (0.62) -2.539 0.012
Status reduction 2.42 (0.70) 2.66 (0.66) -1.865 0.065
Role restriction 2.24 (0.67) 2.72 (0.76) -3.429 0.001
Friendship refusal 2.18 (0.89) 2.44 (0.90) -1.559 0.122
DCFS
Overall score 1.98 (0.62) 2.37 (0.58) -3.375 0.001
Community refusal 1.97 (0.60) 2.43 (0.60) -3.863 <0.001
Causal attribution 2.10 (0.78) 2.31 (0.75) -1.415 0.160
Neglecting_parents 1.75 (0.90) 2.24 (0.93) -2.688 0.008
DCS: Devaluation Consumers’ Scale; DCFS: Devaluation Consumers’ Families Scale; FEP: first-episode psychosis; LTP: long-term psychosis; sd: 
standard deviation.
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5 Link BG, Mirotznik J, Cullen FT. The effectiveness of stigma 
coping orientations: can negative consequences of mental 
illness labeling be avoided? J Health Soc Behav 1991;32:302-
20. 
6 Goffman E. Stigma: notes on the management of spoiled 
identity. 1st edn. New York: Simon & Schuster 1963, p. 153. 
7 Link BG, Cullen FT, Struening E, et al. A modified labeling 
theory approach to mental disorders: an empirical assess-
ment. Am Sociol Rev 1989;54:400-23. 
8 Corrigan P, Watson A, Barr L. The self-stigma of mental ill-
ness: implications for self-esteem and self-efficacy. J Soc Clin 
2006;25:875-84. 
9 Niolu C, Barone Y, Bianciardi E, et al. Predictors of poor 
adherence to treatment in inpatients with bipolar and psy-
chotic spectrum disorders. Riv Psichiatr 2015;50:285-94. 
10 Latalova K, Kamaradova D, Prasko J. Perspectives on per-
ceived stigma and self-stigma in adult male patients with 
depression. Neuropsychiatr Dis Treat 2014;10:1399-405. 
11 Kelly CM, Jorm AF. Stigma and mood disorders. Curr Opin 
Psychiatry 2007;20:13-6. 
12 Mestdagh A, Hansen B. REVIEW: Stigma in patients with 
schizophrenia receiving community mental health care: a 
review of qualitative studies. Soc Psychiatry Psychiatr Epide-
miol 2014;49:79-87. 
13 Magliano L, Fiorillo A, De Rosa C, et al. Beliefs about 
schizophrenia in Italy: a comparative nationwide survey of 
the general public, mental health professionals, and patients’ 
relatives. Can J Psychiatry 2004;49:322-30. 
14 Magliano L, Read J, Rega S, et al. The influence of causal 
explanations and diagnostic labeling on medical students’ 
views of schizophrenia. Acad Med 2011;1155-62. 
15 Mak WWS, Cheung RYM. Affiliate stigma among caregivers 
of people with intellectual disability or mental illness. J Appl 
Res Intellect Disabil 2008;21:532-45. 
16 Van Zels C, Van Nierop M, Oorschot M, et al. Stereotype 
awareness, self-esteem and psychopathology in people with 
psychosis. Mechelli A, editor. PLoS One 2014;9:e88586. 
17 Phelan JC, Bromet EJ, Link BG. Psychiatric illness and family 
stigma. Schizophr Bull 1998;24:115-26. 
18 Pingani L, Forghieri M, Ferrari S, et al. Stigma and discrimi-
nation toward mental illness: translation and validation of 
the Italian version of the attribution questionnaire-27 (AQ-
27-I). Soc Psychiatry Psychiatr Epidemiol 2012;47:993-9. 
19 Magliano L, Fiorillo A, Del Vecchio H, et al. Development 
and validation of a self-reported questionnaire on users’ 
opinions about schizophrenia: a participatory research. Int J 
Soc Psychiatry 2009;55:425-41. 
20 Magliano L, Marasco C, Guarneri M, et al. A new question-
naire assessing the opinions of the relatives of patients with 
schizophrenia on the causes and social consequences of the 
disorder: Reliability and validity. Eur Psychiatry 1999;14:71-5. 
21 Gutiérrez-Maldonado J, Caqueo-Urízar A, Ferrer-García 
M. Effects of a psychoeducational intervention program on 
the attitudes and health perceptions of relatives of patients 
cal stress-response system (the so called “sensitization 
process”). Sensitization determines an impaired response 
to life events and social stress (including minor daily 
life hassles) that, in turn, may trigger delusion and hal-
lucinations, increasing the risk for the onset of psychotic 
disorders or their relapse. Furthermore, anticipated and 
experienced discrimination may affect the course of the 
disease as a maintenance factor, by increasing negative 
affect and social isolation, lowering self-esteem, and fos-
tering ineffective coping strategies1 43-45. Therefore, assess-
ing public stigma in individuals with severe mental disor-
ders might contribute to identify a relevant factor for the 
course and outcome of psychiatric diseases. Strategies to 
reduce discrimination should include both anti-stigma 
interventions, providing the public with information and 
contact with people with psychosis, and provision of psy-
chosocial treatment to people with psychosis to reinforce 
their coping strategies and self-esteem1 46-48. 
The findings of this study should be interpreted with 
caution in light of several limitations, such as: the small 
sample size that might have affected the statistical power, 
the cross-sectional study design preventing inferences on 
causal relations, and the effect of potential, unmeasured 
confounders (i.e., self-esteem, depression, or perceived 
social support) on the association between DCS/DCFS, 
duration of illness, and QUO. Nevertheless, the Italian 
version of DCS and DCFS showed high internal consis-
tency, relevant association with the stage of the disease, 
and mild-to moderate correlations with the QUO and 
the GAF. These encouraging results support the use of 
these scales in clinical and community settings in Italy. 
Moreover, because of their convenience of administra-
tion and the possibility to assess various dimensions of 
public stigma (including affiliate stigma towards family 
members of PWS), DCS and DCFS seem particularly suit-
able to assess public stigma in the community and how it 
is modified in response to anti-stigma campaigns 16 25 41.
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